|Title:||1H-imidazole derivative compounds and pharmaceutical compositions containing the same|
|Abstract:||The 1H-imidazole derivative compound of formula I: ##STR1## and its nontoxic addition salts, particularly the nitrate addition salt, are more effective as antimycotic agents and are unexpectedly safer than the corresponding prior art compounds, especially the compound in which the sulfur atom of the benzothiophene ring of the above compound is replaced by an oxygen atom. Pharmaceutical compositions containing an effective amount of the compound of formula I, e.g. 1 to 5% by weight, in a pharmaceutical carrier are safer, more effective, and, in some cases, more reliable with fewer side effects than currently used antimycotic preparations.|
|Inventor(s):||Foguet; Rafael (Barcelona, ES), Moreno; Marcial (Barcelona, ES), Raga; Manuel (Barcelona, ES), Cuberes; Rosa M. (Barcelona, ES), Castello; Jose M. (Barcelona, ES), Ortiz; Jose A. (Barcelona, ES)|
|Assignee:||Ferrer Internacional S.A. (Barcelona, ES)|
Patent Claim Types:|
see list of patent claims
|Compound; Use; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0151477||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.